Cain A. Hayes was appointed Director of Encompass Health Corp. As of November 14, 2026, Encompass Health Corp has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 2, 2026 to February 20, 2026, naming 2 appointments (Form 8-K, February 2, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Encompass Health Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Encompass Health Corp reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-02 to 2026-02-20. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Encompass Health Corp files it.
Also on the record for Encompass Health Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by T. Rowe Price Associates, Inc. | 5.1% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G/A, by Vanguard Portfolio Management | 4.97% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.26% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Invesco Ltd. | 4.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Encompass Health Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Encompass Health Corp and the records around it.
Encompass Health Corp elsewhere on the record
Companies that share a holder
- Invesco Ltd. also filed stake reports on 93 other companies: Alignment Healthcare Inc (Nov 2026), ArcBest Corp (Nov 2026), Canaan Inc (Nov 2026)
- T. Rowe Price Associates, Inc. also filed stake reports on 191 other companies: PACIFIC BIOSCIENCES OF CALIF (Nov 2026), APARTMENT INVT & MGMT CO -A (Oct 2026), BETA BIONICS INC (Oct 2026)
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
Watch Encompass Health Corp
Get an email when Encompass Health Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Encompass Health Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Encompass Health Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Encompass Health Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-20 | Reported | not named in the filing | 8-K/A, 2026-02-20 | ||
| 2026-02-02 | In | Director | 8-K, 2026-02-02 | ||
| 2026-02-02 | In | 8-K, 2026-02-02 |
Who leads Encompass Health Corp, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Cain A. Hayes, appointed (filed 2026-02-02).
New leaders reset buying decisions — get the Full Report on Encompass Health Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Encompass Health Corp, with the record behind each one.
Find candidates like Director at Encompass Health CorpEvery change, in the filing's words
Reported
This Current Report on Form 8-K amends and supplements the Current Report on Form 8-K originally filed by Encompass Health Corporation (the "Corporation") with the Securities and Exchange Commission on February 2, 2026 related to the appointment of a new member of the Board of Directors (the "Board") of the Corporation.
- On January 30, 2026, the Board unanimously approved the appointment of Cain A. Hayes as director.
- On February 19, 2026, the Board appointed Mr. Hayes to its Compensation and Human Capital Committee and its Compliance and Quality of Care Committee.
Appointed: Cain A. Hayes, Director
On January 30, 2026, the Board of Directors (the "Board") of Encompass Health Corporation (the "Company"), upon the recommendation of its Nominating/Corporate Governance Committee, elected Cain A. Hayes as director.
Appointed: Cain A. Hayes
The Board has not yet appointed Mr. Hayes to a committee.
- The Board has determined Mr. Hayes is independent for purposes of the listing standards of The New York Stock Exchange and the Company's Corporate Governance Guidelines.
- He will be compensated for his board service in accordance with the standard compensation practices for nonemployee directors of the Company, which are more fully described in the "Corporate Governance and Board Structure - Compensation of Directors" section of the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 1, 2025.
Tools for this story
Each opens in a new tab, filled in for Encompass Health Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
